Steps Toward Building Grassroots Support
December 6, 2017 Since the FDA hearing and the FTC workshop in 2015, the homeopathic industry has received more attention than usual from regulators. While AAHP continually meets with congressional…
Recall Preparedness
By Mark Land, AAHP president November 20, 2017 Risks associated with the therapeutic use of healthcare products are real. Manufacturers and the U.S. Food and Drug Administration (FDA) balance these…
Annual Certification of Drug Product Listings
This content is restricted to AAHP members. If you are a member, please login. If you are not a member, click here.Existing Users Log InUsername or EmailPassword Remember Me
What’s New at FDA?
By Mark Land, AAHP president September 1, 2017 I took a course several years ago titled Regulatory Intelligence. The first thing the professor said was, “This course is not designed…
The Road to OTC Monograph Reform
By Barbara A. Kochanowski, senior vice president of regulatory and scientific affairs Consumer Healthcare Products Association August 1, 2017 For the past three years, the regulated industry has been working…
FDA’s Division of Nonprescription Drug Products
By Mark Land, AAHP president August 1, 2017 The development and regulation of over-the-counter (OTC) drug products is the responsibility of the Division of Nonprescription Drug Products (DNDP) within the…
OTC Monograph Reform
By Mark Land, AAHP president August 1, 2017 Self-medication is an important way in which American consumers treat many types of illnesses. Over-the-counter (OTC) drugs often provide effective relief in…
Congress Aiming to Consider User Fee Legislation in July
By Pete Evich, AAHP government relations July 1, 2017 Bills (S 934, HR 2430) that would renew the Food and Drug Administration’s (FDA) ability to collect fees from the drug…
PDUFA after 25 Years
By Mark Land, AAHP president July 1, 2017 The Prescription Drug User Fee Authorization (PDUFA) first enacted in 1992 was the third major piece of drug legislation in the modern…
The Homeopathic Pharmacopoeia of the United States
By Mark Land, AAHP president June 1, 2017 The Homeopathic Pharmacopoeia of the United States (HPUS) is the legal basis for marketing homeopathic drug products in the United States and…
AAHP monitors and reports on current federal regulations, legislation and government policies that affect the homeopathic community. AAHP is often the first to learn of regulatory changes that have both direct and indirect effects on our industry enabling members to stay ahead of the curve in a rapidly changing healthcare environment.
23 Comments
Leave a Comment
You must be logged in to post a comment.
2equitable
pittsburgh gay chat https://bjsgaychatroom.info/
gay dad dating game https://gaypridee.com/
gay chat nyc https://gaytgpost.com/
gay dirty chat https://gay-buddies.com/
list of gay dating sites https://speedgaydate.com/
best time to play slots https://2-free-slots.com/
5.oo slots machine casino https://freeonlneslotmachine.com/
bio dr. jorgen slots https://candylandslotmachine.com/
free slots games for fun https://pennyslotmachines.org/
free igt slots https://slotmachinesworld.com/
free triple diamond slots https://slotmachinesforum.net/
free vegas penny slots https://slot-machine-sale.com/
penny slots https://beat-slot-machines.com/
quick hits free slots https://411slotmachine.com/
hollywood slots bangor https://www-slotmachines.com/
free giants gold slots https://slotmachinegameinfo.com/
help-seeking dissertation https://buydissertationhelp.com/
online dissertation help to write https://dissertationwriting-service.com/
best dissertation writing services uk https://help-with-dissertations.com/
help me with my dissertation https://mydissertationwritinghelp.com/
example of a dissertation https://dissertations-writing.org/
leeds university dissertation help https://helpon-doctoral-dissertations.net/